1d
AZoLifeSciences on MSNNew Cannabinoid Drug Brings Hope For Treating Chronic Pain Without AddictionVIP36, a new CB1 agonist, targets a cryptic pocket to provide analgesia for chronic pain while minimizing side effects and ...
"When mice are full and eat sugar, these nerve cells not only release signaling molecules that stimulate satiety ... The team ...
U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...
Researchers from the German Diabetes Center (DDZ) and the Heinrich Heine University Düsseldorf (HHU) have studied the ...
March 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused ...
The drug is a selective NaV1.8 pain signal inhibitor and has been cleared to treat adults ... Stauffer pointed out that many of the research efforts being put into novel mechanisms and non-opioid ...
And recently, she was the youngest participant in Duke University’s MaryAnn Black Distinguished Health Equity Symposium 2025 where she delivered a presentation on opioid overdose education and ...
At issue: whether opioid settlement money — paid by health care companies that were sued for fueling the opioid crisis and meant to help states abate addiction — should be funneled to two ...
Blocking opiate signaling in this pathway could support current and future obesity treatments. Why do we crave sugary snacks on full stomach? To find out more about the brain's unique mechanism ...
The same nerve cells responsible for signaling fullness after a meal also play a role in triggering a craving for sweets. In both mice and humans, simply perceiving dessert activates this pathway, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results